Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients

Por Gaber, A. Osama, Alloway, Rita R., Bodziak, Kenneth, Kaplan, Bruce, Bunnapradist, Suphamai
Publicado em 2013

A phase III randomized controlled study on the efficacy and improved bowel function of prolonged...

Por Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., Hopp, M.
Publicado no Eur J Pain (2017)

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial

Por Bekker, Linda-Gail, Roux, Surita, Sebastien, Elaine, Yola, Ntando, Amico, K Rivet, Hughes, James P, Marzinke, Mark A, Hendrix, Craig W, Anderson, Peter L, Elharrar, Vanessa, Stirratt, Michael, Rooney, James F, Piwowar-Manning, Estelle, Eshleman, Susan H, McKinstry, Laura, Li, Maoji, Dye, Bonnie J, Grant, Robert M
Publicado no Lancet HIV (2017)

Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three...

Por V. A. Parfenov, E. I. Bogdanov, V. B. Laskov, N. S. Makarov, N. V. Pisova, E. A. Salina, Zh. Yu. Chefranova, L. V. Chichanovskaya
Publicado em 2021-12-01

Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Por Tarakanovskaya, Marina G, Chinburen, Jigjidsuren, Batchuluun, Purev, Munkhzaya, Chogsom, Purevsuren, Genden, Dandii, Dorjiin, Hulan, Tsogkhuu, Oyungerel, Dandii, Kutsyna, Galyna A, Reid, Alan A, Borisova, Vika, Bain, Allen I, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado no J Hepatocell Carcinoma (2017)

Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients...

Por Sun, Alexander, Bae, Kyounghwa, Gore, Elizabeth M., Movsas, Benjamin, Wong, Stuart J., Meyers, Christina A., Bonner, James A., Schild, Steven E., Gaspar, Laurie E., Bogart, Jeffery A., Werner-Wasik, Maria, Choy, Hak
Publicado em 2011

Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis

Por Cornely, O. A., Vehreschild, J. J., Vehreschild, M. J. G. T., Würthwein, G., Arenz, D., Schwartz, S., Heussel, C. P., Silling, G., Mahne, M., Franklin, J., Harnischmacher, U., Wilkens, A., Farowski, F., Karthaus, M., Lehrnbecher, T., Ullmann, A. J., Hallek, M., Groll, A. H.
Publicado em 2011

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

Por Currow, D., Temel, J. S., Abernethy, A., Milanowski, J., Friend, J., Fearon, K. C.
Publicado no Ann Oncol (2017)

Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: Results of a phase 1 study

Por Abramson, J.S., Takvorian, R.W., Fisher, D.C., Feng, Y., Jacobsen, E.D., Brown, J.R., Barnes, J.A., Neuberg, D.S., Hochberg, E.P.
Publicado no Leuk Lymphoma (2013)

Growth performance, organ weights, and blood parameters of nursery pigs fed diets containing increasing levels of cold-pressed canola cake

Por Lee, Jung Wook, Woyengo, Tofuko A
Publicado no J Anim Sci (2018)

Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer

Por Ardizzoni, A, Grossi, F, Scolaro, T, Giudici, S, Foppiano, F, Boni, L, Tixi, L, Cosso, M, Mereu, C, Ratto, G Battista, Vitale, V, Rosso, R
Publicado em 1999

A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation...

Por Michaelson, M. Dror, Hu, Chen, Pham, Huong T., Dahl, Douglas M., Lee-Wu, Chin, Swanson, Gregory P., Vuky, Jacqueline, Lee, R. Jeffrey, Souhami, Luis, Chang, Brian, George, Asha, Sandler, Howard, Shipley, William
Publicado no Int J Radiat Oncol Biol Phys (2016)

Evaluation of conjugated linoleic acid supplementation on markers of joint inflammation and cartilage metabolism in young horses challenged with lipopolysaccharide

Por Bradbery, Amanda N, Coverdale, Josie A, Vernon, Kristine L, Leatherwood, Jessica L, Arnold, Carolyn E, Dabareiner, Robin A, Kahn, Meredith K, Millican, Allison A, Welsh, Thomas H
Publicado no J Anim Sci (2018)

Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours

Por Martin, L P, Kozloff, M F, Herbst, R S, Samuel, T A, Kim, S, Rosbrook, B, Tortorici, M, Chen, Y, Tarazi, J, Olszanski, A J, Rado, T, Starr, A, Cohen, R B
Publicado em 2012

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

Por Camidge, D Ross, Bang, Yung-Jue, Kwak, Eunice L, Iafrate, A John, Varella-Garcia, Marileila, Fox, Stephen B, Riely, Gregory J, Solomon, Benjamin, Ou, Sai-Hong I, Kim, Dong-Wan, Salgia, Ravi, Fidias, Panagiotis, Engelman, Jeffrey A, Gandhi, Leena, Jänne, Pasi A, Costa, Daniel B, Shapiro, Geoffrey I, LoRusso, Patricia, Ruffner, Katherine, Stephenson, Patricia, Tang, Yiyun, Wilner, Keith, Clark, Jeffrey W, Shaw, Alice T
Publicado em 2012

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

Por Pronk, L C, Vasey, P, Sparreboom, A, Reigner, B, Planting, A S Th, Gordon, R J, Osterwalder, B, Verweij, J, Twelves, C
Publicado em 2000

Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study

Por Johansson, Susanne A., Knutsson, Mikael, Leonsson‐Zachrisson, Maria, Rosenbaum, David P.
Publicado no Clin Pharmacol Drug Dev (2017)

A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody...

Por Wilky, B A, Rudek, M A, Ahmed, S, Laheru, D A, Cosgrove, D, Donehower, R C, Nelkin, B, Ball, D, Doyle, L A, Chen, H, Ye, X, Bigley, G, Womack, C, Azad, N S
Publicado no Br J Cancer (2015)

Influence of Tiagabine Maintenance on Cannabis Effects and Related Behaviors in Daily Cannabis Users

Por Wesley, Michael J., Westgate, Philip M., Stoops, William W., Kelly, Thomas H., Hays, Lon R., Lile, Joshua A.
Publicado no Exp Clin Psychopharmacol (2018)

Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results

Por Cortes, Jorge E., Douglas Smith, B., Wang, Eunice S., Merchant, Akil, Oehler, Vivian G., Arellano, Martha, DeAngelo, Daniel J., Pollyea, Daniel A., Sekeres, Mikkael A., Robak, Tadeusz, Ma, Weidong Wendy, Zeremski, Mirjana, Naveed Shaik, M., Douglas Laird, A., O'Connell, Ashleigh, Chan, Geoffrey, Schroeder, Mark A.
Publicado no Am J Hematol (2018)